DB16378InvestigationalProtein Based Therapies
Tefibazumab is under investigation in clinical trial NCT00198289 (Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs).
- Code names
- INH-H 2002
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Tefibazumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account